Detection of <i>MET</i> Polysomy by Next-generation Sequencing and Its Clinical Relevance for <i>MET</i> Inhibitors
Boyang Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhijie Wang(Hubei University of Medicine)
Cited by 13
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization
|Nature Communications|2023|70
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
|Cell Reports Medicine|2023|28
Two-year follow-up of single PD-1 blockade in neoadjuvant resectable NSCLC.
|Journal of Clinical Oncology|2021|5
Noninvasive cancer detection by extracting and integrating multi-modal data from whole-methylome sequencing of plasma cell-free DNA
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3